高级检索
当前位置: 首页 > 详情页

Zhen-wu-tang attenuates cationic bovine serum albumin-induced inflammatory response in membranous glomerulonephritis rat through inhibiting AGEs/RAGE/NF-kappa B pathway activation

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [1] Guangzhou Univ Tradit Chinese Med, Affiliated Hosp 2, Dept Pharm, Guangzhou 510120, Guangdong, Peoples R China [2] Guangzhou Univ Chinese Med, Coll Chinese Mat Med, Dept Pharmacol, 232 WaiHuan East Rd, Guangzhou 510006, Guangdong, Peoples R China [3] Guangzhou Univ Chinese Med, Sci & Technol Pk Co Ltd, Guangzhou 510445, Guangdong, Peoples R China
出处:
ISSN:

摘要:
Zhen-wu-tang (ZWT), a traditional Chinese compound formula recorded in the Treatise on Febrile Diseases, has significant inhibitory effects on inflammatory damage and oxidative lesions in rats, but its mechanism of action remains unclear. The aim of the present study was to explore whether the anti-inflammatory and anti-oxidative effects of ZWT were mediated by the AGEs/RAGE/NF-kappa B signaling pathway in rats with cationic bovine serum albumin (C-BSA)-induced membranous glomerulonephritis (MGN). We found that ZWT significantly reduced the production of malondialdehyde (MDA), but enhanced the superoxide dismutase (SOD) activity. The ELISA results showed that ZWT not only reduced the serum levels of AGEs but also decreased the release of inflammatory mediators (TNF-alpha, IL-1 beta, and IL-6). Meanwhile, HE staining showed that pathological kidney injury was alleviated by ZWT. In addition, ZWT suppressed the expression of RAGE1 and NF-kappa B p65, as well as the nuclear translocation of NF-kappa B p65. The accumulation of AGEs, oxidative lesions and inflammation damage were reduced by an AGE inhibitor. Thus, the present study demonstrates that AGEs play a role in the pathogenesis of MGN and that AGE inhibition could reduce the inflammatory reactions and oxidative lesions in MGN. In general, ZWT attenuated MGN, in part, by inhibiting the AGEs/RAGE/NF-kappa B pathway. (C) 2016 Elsevier B.V. All rights reserved.

语种:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2015]版:
大类 | 3 区 医学
小类 | 3 区 药学 4 区 免疫学
最新[2025]版:
大类 | 2 区 医学
小类 | 2 区 药学 3 区 免疫学
JCR分区:
出版当年[2014]版:
Q2 PHARMACOLOGY & PHARMACY Q3 IMMUNOLOGY
最新[2023]版:
Q1 PHARMACOLOGY & PHARMACY Q2 IMMUNOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2014版] 出版当年五年平均 出版前一年[2013版] 出版后一年[2015版]

第一作者:
第一作者机构: [1] Guangzhou Univ Tradit Chinese Med, Affiliated Hosp 2, Dept Pharm, Guangzhou 510120, Guangdong, Peoples R China
通讯作者:
通讯机构: [*1]Guangzhou Univ Chinese Med, Coll Chinese Mat Med, Dept Pharmacol, 232 WaiHuan East Rd, Guangzhou 510006, Guangdong, Peoples R China [2] Guangzhou Univ Chinese Med, Coll Chinese Mat Med, Dept Pharmacol, 232 WaiHuan East Rd, Guangzhou 510006, Guangdong, Peoples R China
推荐引用方式(GB/T 7714):

资源点击量:2018 今日访问量:0 总访问量:645 更新日期:2024-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 广东省中医院 技术支持:重庆聚合科技有限公司 地址:广州市越秀区大德路111号